Tata Medical Center
Kolkata, India
Medical center in West Bengal
14, MAR(E-W), DH Block(Newtown), Action Area I, Newtown, Kolkata, West Bengal 700160
About Tata Medical Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
7
Tata Medical Center
4
Johnson & Johnson Private Limited
3
Pfizer
3
Karyopharm Therapeutics Inc
2
Bayer
1
Celcuity, Inc.
1
Ferring Pharmaceuticals
1
Hoffmann-La Roche
1
Institute of Cancer Research, United Kingdom
1
Medical University of South Carolina
1
Clinical Trials at Tata Medical Center
During the past decade, Tata Medical Center conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 1 clinical trials were completed, i.e. on
average, 3.7% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 1 clinical trials were completed. i.e. 6.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
2014-11-01
2027-11-01
Recruiting
244
Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment Refractory/Intolerant CML Failing ≥3 Prior CML Therapies
2017-04-25
2026-08-01
Recruiting
303
A Trial to Evaluate Safety of Firmagon® (Degarelix) in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate Cancer
2016-05-01
2020-05-15
Completed
230
Dose Escalation Versus Standard in Laryngopharyngeal Cancers
2016-01-01
2022-12-01
Recruiting
100
Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple Myeloma
2017-05-24
2023-09-01
Active, not recruiting
402
A Study to Assess Safety of ImbruvicaTM in Indian Participants With Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy or Chronic Lymphocytic Leukemia With 17p Deletion
2019-06-26
2023-04-21
Active, not recruiting
75
Performance of MammoAlert™, Point of Care System, for the Screening of Breast Cancer in Women 18 Years of Age or Older
2017-06-17
2018-08-31
Unknown status
2,458
Clinical Outcomes of Chronic Lymphocytic Leukemia (CCL) and Mantle Cell Lymphoma (MCL) Participants Treated With Ibrutinib: A Medical Chart Review From India
2018-04-28
2019-05-31
Completed
40
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Tata Medical Center" #1 sponsor was "Janssen Research & Development, LLC" with 7 trials, followed by "Tata Medical Center" with 4 trials
sponsored, "Johnson & Johnson Private Limited" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "Karyopharm Therapeutics Inc"
with 3 trials sponsored. Other sponsors include 4 different institutions and
companies that sponsored additional 14 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Tata Medical Center"
#1 collaborator was "Indian Society of Critical Care Medicine" with 1 trials as a collaborator, "Kortuc, Inc." with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator, "Orion Corporation, Orion Pharma" with 1 trials as a collaborator and "Pharmacyclics LLC." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Tata Medical Center
According to Clinical.Site data, the most researched conditions in "Tata Medical Center" are
"Multiple Myeloma" (4 trials), "Breast Cancer" (3 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials), "Lymphoma, Mantle-Cell" (3 trials) and "Leukemia, Lymphocytic, Chronic, B-Cell" (2 trials). Many other conditions were trialed in "Tata Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at Tata Medical Center
Most popular intervention types in "Tata Medical Center" are "Drug" (21 trials), "Other" (4 trials), "Radiation" (2 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Amivantamab" (3 trials), "Bortezomib" (3 trials), "Dexamethasone" (3 trials), "Lenalidomide" (3 trials) and "Carboplatin" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Tata Medical Center
The vast majority of trials in "Tata Medical Center" are
23 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.
Clinical Trials Status at Tata Medical Center
Currently, there are NaN active trials in "Tata Medical Center".
undefined are not yet recruiting,
13 are recruiting,
6 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Tata Medical Center,
1 suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Tata Medical Center, 2 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 11 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 5 trials, and there were
also 4 trials that are defined as “Not Applicable".
Departments of Tata Medical Center
Tata Medical Center has several departments that took part in Clinical trials: "TATA Medical Centre; Medical Oncology" - 4 trials, "Tata Medical Center; Department of Medical Oncology" - 2 trials
Departments List
Name
City
Trials